FDA Approved: HERCEPTIN HYLECTA — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved HERCEPTIN HYLECTA (trastuzumab and hyaluronidase-oysk) under an original application by Genentech for treating HER2-positive breast cancer. This pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN HYLECTA (TRASTUZUMAB AND HYALURONIDASE-OYSK)

Snippet

ORIG AP for HERCEPTIN HYLECTA (TRASTUZUMAB AND HYALURONIDASE-OYSK)